AI-generated summary
The authors retrospectively reviewed records of 17 patients with Demodex-associated blepharitis who had not responded to first-line therapy and received intense pulsed light with low-level blue and red light. They report significant improvements in collarettes, saponification, conjunctival hyperemia, corneal staining and symptom scores, with no reported side effects. The study had a small, retrospective design with no control group.
- Participants
- 17
- Who or what was studied
- Patients with Demodex-associated blepharitis resistant to first-line therapy
- Limits stated in the abstract
- The study is retrospective with a small sample of 17 patients and no control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on dovepress.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: GRADE, Low-level laser therapy, Red light therapy, Dry eye. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.